Availability of an Environmental Assessment for Field Testing Fowl Laryngotracheitis-Marek's Disease Vaccine, Serotype 3, Live Marek's Disease Vector, 12932-12933 [2011-5341]
Download as PDF
12932
Notices
Federal Register
Vol. 76, No. 46
Wednesday, March 9, 2011
This section of the FEDERAL REGISTER
contains documents other than rules or
proposed rules that are applicable to the
public. Notices of hearings and investigations,
committee meetings, agency decisions and
rulings, delegations of authority, filing of
petitions and applications and agency
statements of organization and functions are
examples of documents appearing in this
section.
DEPARTMENT OF AGRICULTURE
Animal and Plant Health Inspection
Service
[Docket No. APHIS–2011–0011]
Availability of an Environmental
Assessment for Field Testing Fowl
Laryngotracheitis-Marek’s Disease
Vaccine, Serotype 3, Live Marek’s
Disease Vector
Animal and Plant Health
Inspection Service, USDA.
ACTION: Notice.
AGENCY:
We are advising the public
that the Animal and Plant Health
Inspection Service has prepared an
environmental assessment concerning
authorization to ship for the purpose of
field testing, and then to field test, an
unlicensed Fowl LaryngotracheitisMarek’s Disease Vaccine, Serotype 3,
Live Marek’s Disease Vector. The
environmental assessment, which is
based on a risk analysis prepared for the
field testing of this vaccine, examines
the potential effects that field testing
this veterinary vaccine could have on
the quality of the human environment.
Based on the risk analysis, we have
reached a preliminary determination
that field testing this veterinary vaccine
will not have a significant impact on the
quality of the human environment, and
that an environmental impact statement
need not be prepared. We intend to
authorize shipment of this vaccine for
field testing following the close of the
comment period for this notice unless
new substantial issues bearing on the
effects of this action are brought to our
attention. We also intend to issue a U.S.
Veterinary Biological Product license for
this vaccine, provided the field test data
support the conclusions of the
environmental assessment and the
issuance of a finding of no significant
impact and the product meets all other
requirements for licensing.
Emcdonald on DSK2BSOYB1PROD with NOTICES
SUMMARY:
VerDate Mar<15>2010
18:04 Mar 08, 2011
Jkt 223001
We will consider all comments
that we receive on or before April 8,
2011.
ADDRESSES: You may submit comments
by either of the following methods:
• Federal eRulemaking Portal: Go to
https://www.regulations.gov/fdmspublic/
component/
main?main=DocketDetail&d=APHIS–
2011–0011 to submit or view comments
and to view supporting and related
materials available electronically.
• Postal Mail/Commercial Delivery:
Please send one copy of your comment
to Docket No. APHIS–2011–0011,
Regulatory Analysis and Development,
PPD, APHIS, Station 3A–03.8, 4700
River Road, Unit 118, Riverdale, MD
20737–1238. Please state that your
comment refers to Docket No. APHIS–
2011–0011.
Reading Room: You may read any
comments that we receive on this
docket in our reading room. The reading
room is located in room 1141 of the
USDA South Building, 14th Street and
Independence Avenue SW.,
Washington, DC. Normal reading room
hours are 8 a.m. to 4:30 p.m., Monday
through Friday, except holidays. To be
sure someone is there to help you,
please call (202) 690–2817 before
coming.
Other Information: Additional
information about APHIS and its
programs is available on the Internet at
https://www.aphis.usda.gov.
FOR FURTHER INFORMATION CONTACT: Dr.
Albert P. Morgan, Section Leader,
Operational Support Section, Center for
Veterinary Biologics, Policy, Evaluation,
and Licensing, VS, APHIS, 4700 River
Road Unit 148, Riverdale, MD 20737–
1231; phone (301) 734–8245, fax (301)
734–4314.
For information regarding the
environmental assessment or the risk
analysis, or to request a copy of the
environmental assessment (as well as
the risk analysis with confidential
business information removed), contact
Dr. Patricia L. Foley, Risk Manager,
Center for Veterinary Biologics, Policy,
Evaluation, and Licensing VS, APHIS,
1920 Dayton Avenue, P.O. Box 844,
Ames, IA 50010; phone (515) 337–6100,
fax (515) 337–6120.
SUPPLEMENTARY INFORMATION: Under the
Virus-Serum-Toxin Act (21 U.S.C. 151
et seq.), a veterinary biological product
must be shown to be pure, safe, potent,
and efficacious before a veterinary
DATES:
PO 00000
Frm 00001
Fmt 4703
Sfmt 4703
biological product license may be
issued. A field test is generally
necessary to satisfy prelicensing
requirements for veterinary biological
products. Prior to conducting a field test
on an unlicensed product, an applicant
must obtain approval from the Animal
and Plant Health Inspection Service
(APHIS), as well as obtain APHIS’
authorization to ship the product for
field testing.
To determine whether to authorize
shipment and grant approval for the
field testing of the unlicensed product
referenced in this notice, a risk analysis
has been prepared to assess the
potential effects of this product on the
safety of animals, public health, and the
environment. Based on the risk analysis,
APHIS has prepared an environmental
assessment (EA) concerning the field
testing of the following unlicensed
veterinary biological product:
Requester: Biomune Company.
Product: Fowl LaryngotracheitisMarek’s Disease Vaccine, Serotype 3,
Live Marek’s Disease Vector.
Field Test Locations: Alabama,
Delaware, Pennsylvania, and Texas.
The above-mentioned product
consists of a live recombinant Marek’s
disease virus vector expressing certain
fowl laryngotracheitis virus proteins.
The vaccine is for in ovo vaccination of
18-day-old chick embryos or for the
subcutaneous vaccination of healthy
day-of-age chicks as an aid in the
prevention of Marek’s Disease and
infectious laryngotracheitis.
The EA has been prepared in
accordance with: (1) The National
Environmental Policy Act of 1969
(NEPA), as amended (42 U.S.C. 4321 et
seq.), (2) regulations of the Council on
Environmental Quality for
implementing the procedural provision
of NEPA (40 CFR parts 1500–1508), (3)
USDA regulations implementing NEPA
(7 CFR part 1b), and (4) APHIS’ NEPA
Implementing Procedures (7 CFR part
372).
Unless substantial issues with adverse
environmental impacts are raised in
response to this notice, APHIS intends
to issue a finding of no significant
impact (FONSI) based on the EA and
authorize shipment of the above product
for the initiation of field tests following
the close of the comment period for this
notice.
Because the issues raised by field
testing and by issuance of a license are
E:\FR\FM\09MRN1.SGM
09MRN1
Federal Register / Vol. 76, No. 46 / Wednesday, March 9, 2011 / Notices
identical, APHIS has concluded that the
EA that is generated for field testing
would also be applicable to the
proposed licensing action. Provided that
the field test data support the
conclusions of the original EA and the
issuance of a FONSI, APHIS does not
intend to issue a separate EA and FONSI
to support the issuance of the product
license, and would determine that an
environmental impact statement need
not be prepared. APHIS intends to issue
a veterinary biological product license
for this vaccine following completion of
the field test provided no adverse
impacts on the human environment are
identified and provided the product
meets all other requirements for
licensing.
Authority: 21 U.S.C. 151–159.
Done in Washington, DC, this 4th day of
March 2011.
Kevin Shea,
Acting Administrator, Animal and Plant
Health Inspection Service.
[FR Doc. 2011–5341 Filed 3–8–11; 8:45 am]
BILLING CODE 3410–34–P
individuals will have the opportunity to
address the Committee at that time.
[FR Doc. 2011–5295 Filed 3–8–11; 8:45 am]
BILLING CODE 3410–11–P
Forest Service
Dixie Resource Advisory Committee
ACTION:
Forest Service, USDA.
Notice of meetings.
The Dixie Resource Advisory
Committee will meet in Cedar City,
Utah. The committee is meeting as
authorized under the Secure Rural
Schools and Community SelfDetermination Act (Pub. L. 110–343)
and in compliance with the Federal
Advisory Committee Act. The purpose
of this meeting is to make
recommendations for Title II projects.
The March 16, 2011 meeting has been
cancelled.
SUMMARY:
Forest Service
ADDRESSES:
ACTION:
Emcdonald on DSK2BSOYB1PROD with NOTICES
FOR FURTHER INFORMATION CONTACT:
The Prince of Wales Resource
Advisory Committee will meet in
Thorne Bay, Alaska, March 28, 2011.
The purpose of this meeting is to
discuss potential projects under the
Secure Rural Schools and Community
Self-Determination Act of 2008.
DATES: The meeting will be held March
28, 2011 from 10 a.m. to 4 p.m.
ADDRESSES: The meeting will be held at
the Thorne Bay Ranger District 1312
Federal Way Thorne Bay, Alaska. Send
written comments to Prince of Wales
Resource Advisory Committee, c/o
District Ranger, USDA Forest Service,
P.O. Box 500, Craig, AK 99921, or
electronically to Rebecca Sakraida, RAC
Coordinator at rsakraida@fs.fed.us.
FOR FURTHER INFORMATION CONTACT:
Rebecca Sakraida, RAC Coordinator
Craig Ranger District, Tongass National
Forest, (907) 826–1601.
SUPPLEMENTARY INFORMATION: The
meeting is open to the public.
Committee discussion is limited to
Forest Service staff and Committee
members. However, public input
opportunity will be provided and
SUMMARY:
VerDate Mar<15>2010
18:04 Mar 08, 2011
Jkt 223001
Wednesday, March 30, 2011.
The meeting will be held at
Paiute Tribe of Utah Headquarters, 440
North Paiute Drive (200 East), Cedar
City, Utah. The public is invited to
attend the meetings.
Forest Service, USDA.
Notice of meeting.
Kenton Call, RAC Coordinator, Dixie
National Forest, (435) 865–3730; e-mail:
ckcall@fs.fed.us.
Individuals who use
telecommunication devices for the deaf
(TDD) may call the Federal Information
Relay Service (FIRS) at 1–800–877–8339
between 8 a.m. and 8 p.m., Eastern
Standard Time, Monday through Friday.
The
meeting is open to the public. The
following business will be conducted:
(1) Welcome and committee
introductions; (2) review of category
voting from previous meeting; (3)
discussion of RAC project
recommendations; and (4) public
comment on any proposals. Persons
who wish to bring related matters to the
attention of the Committee may file
written statements with the Committee
staff before or after the meeting. Public
input will be accepted by the RAC
during the meetings.
SUPPLEMENTARY INFORMATION:
Dated: March 3, 2011.
Robert G. MacWhorter,
Forest Supervisor.
[FR Doc. 2011–5297 Filed 3–8–11; 8:45 am]
BILLING CODE 3410–11–P
PO 00000
Frm 00002
Fmt 4703
Forest Service, USDA.
Notice of meetings.
AGENCY:
DEPARTMENT OF AGRICULTURE
DATES:
AGENCY:
North Central Idaho Resource
Advisory Committee
ACTION:
DEPARTMENT OF AGRICULTURE
Prince of Wales Resource Advisory
Committee
DEPARTMENT OF AGRICULTURE
Forest Service
Francisco B. Sanchez,
District Ranger.
AGENCY:
12933
Sfmt 4703
The North Central Idaho RAC
will meet in Grangeville, Idaho. The
committee is meeting as authorized
under the Secure Rural Schools and
Community Self-Determination Act
(Pub. L. 110–343) and in compliance
with the Federal Advisory Committee
Act. The purpose of the meeting is to
select projects for 2011 and hear
presentations on 2012 projects. The
February 23–24 RAC meeting was
cancelled due to inclement weather.
DATES: The meeting will be held on
March 24th and 25th 2011, at 10 a.m.
(PST).
ADDRESSES: The meeting will be held at
the Nez Perce National Forest
Supervisors Office, 104 Airport Road,
Grangeville, Idaho. Written comments
should be sent to Laura Smith at 104
Airport Road in Grangeville, Idaho
83530. Comments may also be sent via
e-mail to lasmith@fs.fed.us or via
facsimile to Laura at 208–983–4099.
FOR FURTHER INFORMATION CONTACT:
Laura Smith, Designated Forest Official
at 208–983–5143.
SUPPLEMENTARY INFORMATION: The
meeting is open to the public. A public
forum will begin at 3:15 p.m. (PST) on
the first meeting day. The following
business will be conducted: Comments
and questions from the public to the
committee. Persons who wish to bring
related matters to the attention of the
Committee may file written statements
with the Committee staff before or after
the meeting.
SUMMARY:
Dated: March 1, 2011.
Rick Brazell,
Forest Supervisor.
[FR Doc. 2011–5106 Filed 3–8–11; 8:45 am]
BILLING CODE 3410–11–P
DEPARTMENT OF COMMERCE
Submission for OMB Review;
Comment Request
The Department of Commerce will
submit to the Office of Management and
Budget (OMB) for clearance the
following proposal for collection of
information under the provisions of the
Paperwork Reduction Act (44 U.S.C.
chapter 35).
Agency: Bureau of Industry and
Security.
E:\FR\FM\09MRN1.SGM
09MRN1
Agencies
[Federal Register Volume 76, Number 46 (Wednesday, March 9, 2011)]
[Notices]
[Pages 12932-12933]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2011-5341]
========================================================================
Notices
Federal Register
________________________________________________________________________
This section of the FEDERAL REGISTER contains documents other than rules
or proposed rules that are applicable to the public. Notices of hearings
and investigations, committee meetings, agency decisions and rulings,
delegations of authority, filing of petitions and applications and agency
statements of organization and functions are examples of documents
appearing in this section.
========================================================================
Federal Register / Vol. 76, No. 46 / Wednesday, March 9, 2011 /
Notices
[[Page 12932]]
DEPARTMENT OF AGRICULTURE
Animal and Plant Health Inspection Service
[Docket No. APHIS-2011-0011]
Availability of an Environmental Assessment for Field Testing
Fowl Laryngotracheitis-Marek's Disease Vaccine, Serotype 3, Live
Marek's Disease Vector
AGENCY: Animal and Plant Health Inspection Service, USDA.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: We are advising the public that the Animal and Plant Health
Inspection Service has prepared an environmental assessment concerning
authorization to ship for the purpose of field testing, and then to
field test, an unlicensed Fowl Laryngotracheitis-Marek's Disease
Vaccine, Serotype 3, Live Marek's Disease Vector. The environmental
assessment, which is based on a risk analysis prepared for the field
testing of this vaccine, examines the potential effects that field
testing this veterinary vaccine could have on the quality of the human
environment. Based on the risk analysis, we have reached a preliminary
determination that field testing this veterinary vaccine will not have
a significant impact on the quality of the human environment, and that
an environmental impact statement need not be prepared. We intend to
authorize shipment of this vaccine for field testing following the
close of the comment period for this notice unless new substantial
issues bearing on the effects of this action are brought to our
attention. We also intend to issue a U.S. Veterinary Biological Product
license for this vaccine, provided the field test data support the
conclusions of the environmental assessment and the issuance of a
finding of no significant impact and the product meets all other
requirements for licensing.
DATES: We will consider all comments that we receive on or before April
8, 2011.
ADDRESSES: You may submit comments by either of the following methods:
Federal eRulemaking Portal: Go to https://www.regulations.gov/fdmspublic/component/main?main=DocketDetail&d=APHIS-2011-0011 to submit or view comments and
to view supporting and related materials available electronically.
Postal Mail/Commercial Delivery: Please send one copy of
your comment to Docket No. APHIS-2011-0011, Regulatory Analysis and
Development, PPD, APHIS, Station 3A-03.8, 4700 River Road, Unit 118,
Riverdale, MD 20737-1238. Please state that your comment refers to
Docket No. APHIS-2011-0011.
Reading Room: You may read any comments that we receive on this
docket in our reading room. The reading room is located in room 1141 of
the USDA South Building, 14th Street and Independence Avenue SW.,
Washington, DC. Normal reading room hours are 8 a.m. to 4:30 p.m.,
Monday through Friday, except holidays. To be sure someone is there to
help you, please call (202) 690-2817 before coming.
Other Information: Additional information about APHIS and its
programs is available on the Internet at https://www.aphis.usda.gov.
FOR FURTHER INFORMATION CONTACT: Dr. Albert P. Morgan, Section Leader,
Operational Support Section, Center for Veterinary Biologics, Policy,
Evaluation, and Licensing, VS, APHIS, 4700 River Road Unit 148,
Riverdale, MD 20737-1231; phone (301) 734-8245, fax (301) 734-4314.
For information regarding the environmental assessment or the risk
analysis, or to request a copy of the environmental assessment (as well
as the risk analysis with confidential business information removed),
contact Dr. Patricia L. Foley, Risk Manager, Center for Veterinary
Biologics, Policy, Evaluation, and Licensing VS, APHIS, 1920 Dayton
Avenue, P.O. Box 844, Ames, IA 50010; phone (515) 337-6100, fax (515)
337-6120.
SUPPLEMENTARY INFORMATION: Under the Virus-Serum-Toxin Act (21 U.S.C.
151 et seq.), a veterinary biological product must be shown to be pure,
safe, potent, and efficacious before a veterinary biological product
license may be issued. A field test is generally necessary to satisfy
prelicensing requirements for veterinary biological products. Prior to
conducting a field test on an unlicensed product, an applicant must
obtain approval from the Animal and Plant Health Inspection Service
(APHIS), as well as obtain APHIS' authorization to ship the product for
field testing.
To determine whether to authorize shipment and grant approval for
the field testing of the unlicensed product referenced in this notice,
a risk analysis has been prepared to assess the potential effects of
this product on the safety of animals, public health, and the
environment. Based on the risk analysis, APHIS has prepared an
environmental assessment (EA) concerning the field testing of the
following unlicensed veterinary biological product:
Requester: Biomune Company.
Product: Fowl Laryngotracheitis-Marek's Disease Vaccine, Serotype
3, Live Marek's Disease Vector.
Field Test Locations: Alabama, Delaware, Pennsylvania, and Texas.
The above-mentioned product consists of a live recombinant Marek's
disease virus vector expressing certain fowl laryngotracheitis virus
proteins. The vaccine is for in ovo vaccination of 18-day-old chick
embryos or for the subcutaneous vaccination of healthy day-of-age
chicks as an aid in the prevention of Marek's Disease and infectious
laryngotracheitis.
The EA has been prepared in accordance with: (1) The National
Environmental Policy Act of 1969 (NEPA), as amended (42 U.S.C. 4321 et
seq.), (2) regulations of the Council on Environmental Quality for
implementing the procedural provision of NEPA (40 CFR parts 1500-1508),
(3) USDA regulations implementing NEPA (7 CFR part 1b), and (4) APHIS'
NEPA Implementing Procedures (7 CFR part 372).
Unless substantial issues with adverse environmental impacts are
raised in response to this notice, APHIS intends to issue a finding of
no significant impact (FONSI) based on the EA and authorize shipment of
the above product for the initiation of field tests following the close
of the comment period for this notice.
Because the issues raised by field testing and by issuance of a
license are
[[Page 12933]]
identical, APHIS has concluded that the EA that is generated for field
testing would also be applicable to the proposed licensing action.
Provided that the field test data support the conclusions of the
original EA and the issuance of a FONSI, APHIS does not intend to issue
a separate EA and FONSI to support the issuance of the product license,
and would determine that an environmental impact statement need not be
prepared. APHIS intends to issue a veterinary biological product
license for this vaccine following completion of the field test
provided no adverse impacts on the human environment are identified and
provided the product meets all other requirements for licensing.
Authority: 21 U.S.C. 151-159.
Done in Washington, DC, this 4th day of March 2011.
Kevin Shea,
Acting Administrator, Animal and Plant Health Inspection Service.
[FR Doc. 2011-5341 Filed 3-8-11; 8:45 am]
BILLING CODE 3410-34-P